Tricyclic antidepressants (TCAs) include:
There is no evidence that these medications deplete any nutrients.
Gold Standard Drug Database: Drug Monograph: Amitriptyline, 2016. www.clinicalkey.com/#!/content/drug_monograph/6-s2.0-26. Accessed July7, 2016.
Gold Standard Drug Database: Drug Monograph: Amoxapine, 2016. www.clinicalkey.com/#!/content/drug_monograph/6-s2.0-30. Accessed July7, 2016.
Gold Standard Drug Database: Drug Monograph: Desipramine, 2016. www.clinicalkey.com/#!/content/drug_monograph/6-s2.0-172. Accessed July7, 2016.
Gold Standard Drug Database: Drug Monograph: Doxepin 2016. www.clinicalkey.com/#!/content/drug_monograph/6-s2.0-210. Accessed July7, 2016.
Gold Standard Drug Database: Drug Monograph: Imipramine 2016. www.clinicalkey.com/#!/content/drug_monograph/6-s2.0-309. Accessed July7, 2016.
Gold Standard Drug Database: Drug Monograph: Protriptyline, 2016. www.clinicalkey.com/#!/content/drug_monograph/6-s2.0-525. Accessed July7, 2016.
Gold Standard Drug Database: Drug Monograph: Trimipramine 2016. www.clinicalkey.com/#!/content/drug_monograph/6-s2.0-1603. Accessed July7, 2016.
Gold Standard Drug Database: Drug Monograph:Nortriptyline 2016. www.clinicalkey.com/#!/content/drug_monograph/6-s2.0-447. Accessed July7, 2016.
Reviewed By: Steven D. Ehrlich, NMD, Solutions Acupuncture, a private practice specializing in complementary and alternative medicine, Phoenix, AZ. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Isla Ogilvie, PhD, and the A.D.A.M. Editorial team.
Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. |
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- 2024 A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.